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Abstract We present a rare case of focal neuromyotonia
in a 73-year-old woman with a follow up of 5 years. The
clinical picture showed a fixed contraction of the 3rd and
4th finger of the left hand. Similar to other published cases,
our patient suffered from COPD and was treated with beta-
2-sympathomimetics. This clinical picture shows a rare but
rather salient differential diagnosis of Dupuytren’s con-
tracture. EMG of the affected muscles may yield a diag-
nosis and prevent the patient from a long and ineffective
treatment ‘‘odyssey’’.
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Case
We present the case of a 73-year-old woman with a gradual
onset of painless flexion of her 3rd and 4th fingers on the
left hand. In suspicion of a tendovaginitis stenosans, the
ringbands of these fingers were operatively opened without
any improvement. Examination revealed fixed contractions
(Fig. 1). No weakness of the arm and hand muscles, no
percussion myotonia, and no loss of sensibility or reflexes
were found. Otherwise the neurological examination was
normal.
Injections of 50 MU Botulinumtoxin-A into the flexor
digitorum superficialis, and 60 MU into the intrinsic hand
muscles in a second session, did not result in any
improvement. During the EMG-controlled injection,
spontaneous muscle activity in the form of neuromyotonic
discharges of up to 30 s was found in the following mus-
cles on the left: extensor digitorum communis, biceps
brachii, flexor digitorum superficialis, flexor carpi ulnaris
and brachioradialis.
The relevant medical history included severe chronic
obstructive pulmonary disease (COPD) with centrilobular
emphysema, of onset following partial lung resection for
squamous cell carcinoma 6 years earlier. In the same year
the patient required a pacemaker because of AV block and
atrial fibrillation. She also had mild renal impairment and
peripheral artery occlusive disease. Her treatment included
prednisolone (25 mg per day) and salmeterol (50 lg as
needed), aspirin, a statin, and antihypertensives (incl.
betablockers).
On follow up after 5 years, the clinical picture (Fig. 1), as
well as the neurological examination remained unchanged.
Neuromyotonic discharges were found only in the flexor
digitorum superficialis on the left side (Fig. 2). There was no
pathological spontaneous activity in the extensor digitorum
on the left or in the flexor digitorum on the right.
Discussion
We present a rare case of focal neuromyotonia. There are
only a few other cases published [1–3]. However, this form
of neuromyotonia might well be underdiagnosed. These
A. R. Gantenbein  M. Wiederkehr  G. Schwegler
Department of Neurology, Cantonal Hospital,
Aarau, Switzerland
A. R. Gantenbein (&)
Department of Neurology, University Hospital Zurich,
Frauenklinikstrasse 26, 8091 Zu¨rich, Switzerland
e-mail: andreas.gantenbein@usz.ch
C. Meuli-Simmen
Division of Plastic, Reconstructive, and Hand Surgery,
Cantonal Hospital, Aarau, Switzerland
123
J Neurol (2010) 257:1727–1729
DOI 10.1007/s00415-010-5612-6
patients are typically seen in an outpatient hand-surgery or
rheumatology clinic, and may be misdiagnosed as
Dupuytren’s contracture or fixed trigger finger. Some are
even operated on, albeit unsuccessfully. The neuromyo-
tonic discharges during EMG-assisted botox-injection led
to the diagnosis of a focal neuromyotonia. Further diag-
nostic tests (such as voltage-gated potassium channel anti-
bodies) were declined by the patient. However, the focal
phenotype remained unchanged in the 5 years follow up.
In similarity to the other published cases [1, 2], our
patient presented suffered from COPD and was treated with
beta-2-sympathomimetics. Enhancement of axonal hyper-
excitability due to hypoxia (from COPD) and effects on
sodium–potassium pumps, leading to hyperpolarisation
through activation by sympathomimetics, may be poten-
tially contributory [4, 5]. However, the exact mechanisms
by which a few elderly patients with similar disposition
develop this rare neuromuscular disease, especially with
such a focal phenotype, remain unclear. In our case, we
note that the Botox injections had no effect on the con-
tractions. As botulinum toxin A acts through praesynaptic
inhibition of acetylcholine release [6], we would hypo-
thesise either a mechanical dysfunction by transformation
of muscle into fibrous tissue, or an additional postsynaptic
mechanism at the neuromuscular junction or the muscle
itself as underlying pathology.
This clinical picture shows a rare but rather salient
differential diagnosis of Dupuytren’s contracture. In atypi-
cal cases, particularly in patients with COPD, a referral to
Fig. 2 EMG in the left flexor
digitorum superficialis muscle
showing neuromyotonic bursts
(spontaneous high frequency
discharges with waning
amplitudes and abrupt ending)
Fig. 1 Opening the left hand, one can perceive the sign of the Devil’s
horns (‘‘mano cornuto’’). But, this is also the symbol for ‘‘I love you’’
in sign language
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a neurologist might be helpful. EMG of the affected
muscles may yield a diagnosis and prevent the patient from
a long and ineffective treatment ‘‘odyssey’’.
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